| Slide sheets for moving or repositioning a person: late-stage assessment | HTE23 | | |
| Falls: assessment and prevention in older people and in people 50 and over at higher risk | NG249 | | |
| Falls | QS86 | | |
| Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over | HST33 | | |
| Tislelizumab in combination for untreated advanced non-small-cell lung cancer (terminated appraisal) | TA1058 | | |
| Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labour | IPG800 | | |
| Robot-assisted surgery for soft tissue procedures: early value assessment | HTE21 | | |
| Robot-assisted surgery for orthopaedic procedures: early value assessment | HTE22 | | |
| Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy | TA1055 | | |
| Molnupiravir for treating COVID-19 | TA1056 | | |
| Relugolix–estradiol–norethisterone for treating symptoms of endometriosis | TA1057 | | |
| Cladribine for treating active relapsing forms of multiple sclerosis | TA1053 | | |
| Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over | TA1054 | | |
| Early and locally advanced breast cancer: diagnosis and management | NG101 | | |
| Burosumab for treating X-linked hypophosphataemia in children and young people | HST8 | | |
| Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B | HST32 | | |
| Efanesoctocog alfa for treating and preventing bleeding episodes in haemophilia A in people 2 years and over | TA1051 | | |
| Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer (terminated appraisal) | TA1052 | | |